LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | barcode | cell_count | frac_dead | corpse_count | cell_count_dead | row | column | agent | concentration | role | timepoint | replicate | cell_line | dead_count | fraction_dead | cell_count__time0 | dead_count__time0 | cell_count__ctrl | dead_count__ctrl | fraction_dead__ctrl | increase_fraction_dead | GRvalue |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trametinib | 180622_BG_7 | 2569 | 0.0500 | 72 | 60 | 12 | 3 | Trametinib | 0.00998 | treatment | 72 | 2 | MCF10A-GM_5 | 132 | 0.0489 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.02275 | 0.2785 |
Palbociclib | 180614_BG_04 | 3499 | 0.0383 | 77 | 60 | 9 | 18 | Palbociclib | 3.160329361 | treatment | 72 | 1 | MCF10A-GM_8 | 137 | 0.0377 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.01768 | 0.3792 |
Palbociclib | 180614_BG_03 | 4268 | 0.0344 | 90 | 60 | 6 | 6 | Palbociclib | 0.997999609 | treatment | 72 | 1 | MCF10A-GM_4 | 150 | 0.0340 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.01396 | 0.4450 |
Etoposide | 180622_BG_7 | 896 | 0.1452 | 82 | 60 | 14 | 16 | Etoposide | 9.98 | treatment | 72 | 2 | MCF10A-GM_6 | 142 | 0.1368 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.11068 | 0.0163 |
Palbociclib | 180703_BG_11 | 6708 | 0.0269 | 124 | 60 | 6 | 18 | Palbociclib | 3.160329361 | treatment | 72 | 3 | MCF10A-GM_4 | 184 | 0.0267 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | -0.00510 | 0.4890 |
Neratinib | 180614_BG_03 | 1766 | 0.0627 | 53 | 61 | 9 | 8 | Neratinib | 0.997999609 | treatment | 72 | 1 | MCF10A-GM_5 | 114 | 0.0606 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.04064 | 0.1748 |
Trametinib | 180703_BG_12 | 4419 | 0.0300 | 74 | 61 | 7 | 22 | Trametinib | 0.00998 | treatment | 72 | 3 | MCF10A-GM_9 | 135 | 0.0296 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | -0.00215 | 0.3400 |
Etoposide | 180622_BG_6 | 1052 | 0.1024 | 52 | 61 | 6 | 18 | Etoposide | 0.997999808 | treatment | 72 | 2 | MCF10A-GM_3 | 113 | 0.0970 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.07087 | 0.0525 |
Neratinib | 180614_BG_03 | 1577 | 0.0829 | 76 | 61 | 3 | 12 | Neratinib | 0.997999609 | treatment | 72 | 1 | MCF10A-GM_4 | 137 | 0.0799 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.05993 | 0.1440 |
Palbociclib | 180614_BG_02 | 3863 | 0.0308 | 60 | 61 | 12 | 13 | Palbociclib | 0.997999609 | treatment | 72 | 1 | MCF10A-GM_3 | 121 | 0.0304 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.01038 | 0.4116 |
Palbociclib | 180622_BG_6 | 4949 | 0.0401 | 143 | 61 | 7 | 13 | Palbociclib | 0.997999609 | treatment | 72 | 2 | MCF10A-GM_1 | 204 | 0.0396 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.01346 | 0.4749 |
Vorinostat | 180703_BG_12 | 2107 | 0.0563 | 61 | 61 | 12 | 16 | Vorinostat | 9.98 | treatment | 72 | 3 | MCF10A-GM_9 | 122 | 0.0547 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.02293 | 0.1113 |
Neratinib | 180622_BG_8 | 1764 | 0.0705 | 67 | 62 | 4 | 22 | Neratinib | 3.160329364 | treatment | 72 | 2 | MCF10A-GM_7 | 129 | 0.0681 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.04202 | 0.1780 |
Etoposide | 180614_BG_04 | 1143 | 0.1317 | 102 | 62 | 12 | 4 | Etoposide | 3.193598006 | treatment | 72 | 1 | MCF10A-GM_9 | 164 | 0.1255 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.10548 | 0.0608 |
Neratinib | 180703_BG_11 | 2697 | 0.0692 | 134 | 62 | 9 | 20 | Neratinib | 3.160329364 | treatment | 72 | 3 | MCF10A-GM_6 | 196 | 0.0677 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.03595 | 0.1828 |
Vorinostat | 180614_BG_04 | 2822 | 0.0701 | 146 | 62 | 9 | 17 | Vorinostat | 3.193598006 | treatment | 72 | 1 | MCF10A-GM_8 | 208 | 0.0686 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.04865 | 0.3113 |
Etoposide | 180614_BG_02 | 1107 | 0.0945 | 47 | 62 | 6 | 18 | Etoposide | 0.997999808 | treatment | 72 | 1 | MCF10A-GM_3 | 109 | 0.0896 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.06964 | 0.0528 |
Etoposide | 180703_BG_11 | 2406 | 0.0829 | 150 | 62 | 8 | 5 | Etoposide | 0.997999808 | treatment | 72 | 3 | MCF10A-GM_5 | 212 | 0.0810 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.04918 | 0.1492 |
Palbociclib | 180622_BG_6 | 5819 | 0.0292 | 111 | 62 | 4 | 21 | Palbociclib | 0.332666627 | treatment | 72 | 2 | MCF10A-GM_2 | 173 | 0.0289 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.00275 | 0.5279 |
Trametinib | 180703_BG_10 | 3119 | 0.0384 | 60 | 62 | 4 | 3 | Trametinib | 0.319359801 | treatment | 72 | 3 | MCF10A-GM_2 | 122 | 0.0376 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.00584 | 0.2270 |
Neratinib | 180614_BG_03 | 4630 | 0.0318 | 88 | 62 | 14 | 9 | Neratinib | 0.299399965 | treatment | 72 | 1 | MCF10A-GM_6 | 150 | 0.0314 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.01139 | 0.4729 |
Trametinib | 180614_BG_02 | 1752 | 0.0570 | 39 | 63 | 6 | 4 | Trametinib | 0.031603332 | treatment | 72 | 1 | MCF10A-GM_1 | 102 | 0.0550 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.03502 | 0.1726 |
Palbociclib | 180703_BG_12 | 6136 | 0.0238 | 85 | 63 | 7 | 20 | Palbociclib | 10.01326667 | treatment | 72 | 3 | MCF10A-GM_8 | 148 | 0.0236 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | -0.00825 | 0.4558 |
Etoposide | 180622_BG_7 | 952 | 0.1386 | 80 | 63 | 14 | 17 | Etoposide | 3.193598006 | treatment | 72 | 2 | MCF10A-GM_6 | 143 | 0.1306 | 832.0 | 168.3 | 20016 | 537.9 | 0.0261 | 0.10447 | 0.0298 |
Trametinib | 180703_BG_11 | 3117 | 0.0571 | 122 | 63 | 8 | 10 | Trametinib | 0.998 | treatment | 72 | 3 | MCF10A-GM_4 | 185 | 0.0560 | 1387.8 | 74.9 | 21564 | 711.9 | 0.0318 | 0.02423 | 0.2268 |